EconPapers    
Economics at your fingertips  
 

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

Sabine Steffens, Niels R. Veillard, Claire Arnaud, Graziano Pelli, Fabienne Burger, Christian Staub, Andreas Zimmer, Jean-Louis Frossard and François Mach ()
Additional contact information
Sabine Steffens: University Hospital, Faculty of Medicine
Niels R. Veillard: University Hospital, Faculty of Medicine
Claire Arnaud: University Hospital, Faculty of Medicine
Graziano Pelli: University Hospital, Faculty of Medicine
Fabienne Burger: University Hospital, Faculty of Medicine
Christian Staub: University Hospital, Faculty of Medicine
Andreas Zimmer: University of Bonn
Jean-Louis Frossard: University Hospital, Faculty of Medicine
François Mach: University Hospital, Faculty of Medicine

Nature, 2005, vol. 434, issue 7034, 782-786

Abstract: Cardiovascular action of THC The immunosuppressive and anti-inflammatory effects of cannabinoids are well documented, and pre-clinical studies provide the rationale for their use to treat autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. Atherosclerosis is now recognized as a chronic inflammatory disease of the large arteries, so it made sense to test the effects of the cannabinoid THC in a mouse atherosclerosis model. Oral administration of THC does indeed have a beneficial effect on established atherosclerosis in mice, at a surprisingly low dose, suggesting a novel use of this drug in cardiovascular diseases.

Date: 2005
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/nature03389 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:434:y:2005:i:7034:d:10.1038_nature03389

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature03389

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:434:y:2005:i:7034:d:10.1038_nature03389